Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany

PURPOSE: To describe the characteristics of new users of cilostazol in Europe with the aim to support the evaluation of its benefit/risk as used in regular clinical practice before the implementation of labeling changes recommended by the European Medicines Agency. METHODS: New users of cilostazol w...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellsague, Jordi, Perez‐Gutthann, Susana, Calingaert, Brian, Bui, Christine, Varas‐Lorenzo, Cristina, Arana, Alejandro, Prados‐Torres, Alexandra, Poblador‐Plou, Beatriz, Gonzalez‐Rubio, Francisca, Giner‐Soriano, Maria, Roso‐Llorach, Albert, Linder, Marie, Citarella, Anna, Scholle, Oliver, Blenk, Tilo, Garbe, Edeltraut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484386/
https://www.ncbi.nlm.nih.gov/pubmed/28133890
http://dx.doi.org/10.1002/pds.4167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484386/
https://www.ncbi.nlm.nih.gov/pubmed/28133890
http://dx.doi.org/10.1002/pds.4167

Ejemplares similares